Before peptide therapy, a provider may evaluate markers such as baseline hormones, testosterone, estrogen, IGF-1, fasting glucose, insulin response, liver enzymes, kidney function, cholesterol levels, inflammatory markers, and blood pressure
Other known molecular targets of neurosteroids include various TRP channels (151, 152), serotonin receptors and L-Type VGCCs ( 2+ influx via TRPM3 channels in pancreatic beta cells (151)
It also provides comparison periods to evaluate whether the peptide is actually contributing to your results
Route of Administration: Oral gavage, subcutaneous injection, intraperitoneal injection each route has distinct implications for absorption, bioavailability, and systemic exposure